4.12. Assessment of Neuroprotective Activity and MTT Assay

DC Despina Charalambous
MC Michalis Christoforou
KC Krystallo Christou
MC Melina Christou
AV Antonis Ververis
MA Marios Andreou
KC Kyproula Christodoulou
AK Andrie Koutsoulidou
CP Christoforos Papachrysostomou
MP Maria Pantelidou
request Request a Protocol
ask Ask a question
Favorite

The MTT assay evaluated the SH-SY5Y cell viability after treatment with S. officinalis extracts, Aβ25–35 peptides, or the combination of both extracts and peptides, as previously described [50]. The SH-SY5Y cells were cultured for 24 h at a density of 2 × 105 cells/well in a 96-well plate. The next day, the cells were treated with different concentrations of the S. officinalis extracts, or 25 μM of Aβ25–35 peptides, or a combination of both for 48 h. Then, the cells were incubated in DMEM without phenol red that contained 45 μg/mL MTT for 4 h at 37 °C. Following aspiration of the medium, 150 μL of DMSO was added to each well. After covering the plate with foil and shaking it for 15 min, the absorbance was measured at 590 nm using a Synergy H1 microplate reader (BioTek® Instruments, Inc., Winooski, VT, USA). Cell viability was calculated using the following equation:

At least four independent experiments were performed.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A